7966 related articles for article (PubMed ID: 15386939)
1. Anti-tumor effects of pNEgr-mIL-12 recombinant plasmid induced by X-irradiation and its mechanisms.
Yang Y; Liu SZ; Fu SB
Biomed Environ Sci; 2004 Jun; 17(2):135-43. PubMed ID: 15386939
[TBL] [Abstract][Full Text] [Related]
2. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of pEgr-IL18-B7.2 gene radiotherapy in B16 melanoma-bearing mice.
Yang J; Jin G; Liu X; Liu S
Hum Gene Ther; 2007 Apr; 18(4):323-32. PubMed ID: 17411412
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effect of pEgr-IFNgamma gene-radiotherapy in B16 melanoma-bearing mice.
Wu CM; Li XY; Huang TH
World J Gastroenterol; 2004 Oct; 10(20):3011-5. PubMed ID: 15378784
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
Yin XL; Duan H; Peng ZP; Sun SL; Li SL
Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
[TBL] [Abstract][Full Text] [Related]
6. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
Yin X; Yan X; Yang Q; Cao H; Liang H
Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.
Yang W; Li XY
Chin Med J (Engl); 2005 Feb; 118(4):296-301. PubMed ID: 15740667
[TBL] [Abstract][Full Text] [Related]
8. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.
Pan J; Zhang M; Wang J; Wang Q; Xia D; Sun W; Zhang L; Yu H; Cao X
J Cancer Res Clin Oncol; 2005 Jul; 131(7):468-78. PubMed ID: 15711825
[TBL] [Abstract][Full Text] [Related]
10. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.
Kishida T; Asada H; Satoh E; Tanaka S; Shinya M; Hirai H; Iwai M; Tahara H; Imanishi J; Mazda O
Gene Ther; 2001 Aug; 8(16):1234-40. PubMed ID: 11509956
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
Björkdahl O; Dohlsten M; Sjögren HO
Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
[TBL] [Abstract][Full Text] [Related]
12. Effect of pEgr-TNFalpha gene radiotherapy on mice melanoma.
Wu C; Li X; Tian M
Melanoma Res; 2005 Jun; 15(3):185-90. PubMed ID: 15917700
[TBL] [Abstract][Full Text] [Related]
13. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
Aravindaram K; Wang PH; Yin SY; Yang NS
Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
[TBL] [Abstract][Full Text] [Related]
15. IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice.
Harada N; Shimada M; Okano S; Suehiro T; Soejima Y; Tomita Y; Maehara Y
J Immunol; 2004 Dec; 173(11):6635-44. PubMed ID: 15557154
[TBL] [Abstract][Full Text] [Related]
16. [Construction of pEgr-TNFalpha plasmid and experimental study on the effect of gene-radiotherapy on mouse melanoma].
Wu CM; Li XY
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):143-5. PubMed ID: 15196432
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity.
Hsieh CT; Luo YH; Chien CS; Wu CH; Tseng PC; Chiou SH; Lee YC; Whang-Peng J; Chen YM
J Immunother; 2016 May; 39(4):153-9. PubMed ID: 27023059
[TBL] [Abstract][Full Text] [Related]
18. Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy.
Zheng S; Xiao ZX; Pan YL; Han MY; Dong Q
World J Gastroenterol; 2003 May; 9(5):951-5. PubMed ID: 12717836
[TBL] [Abstract][Full Text] [Related]
19. Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice.
Zhao F; Dou J; Wang J; Chu L; Tang Q; Wang Y; Li Y; Cao M; Hu W; Hu K; Feng He X; Gu N
Immunobiology; 2010; 215(2):89-100. PubMed ID: 19457579
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice.
Lasek W; Mackiewicz A; Czajka A; Switaj T; Goł b J; Wiznerowicz M; Korczak-Kowalska G; Bakowiec-Iskra EZ; Gryska K; Izycki D; Jakóbisiak M
Cancer Gene Ther; 2000 Dec; 7(12):1581-90. PubMed ID: 11228537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
